Efficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus

Background. The increasing incidence of metabolism-associated steatotic liver disease (MASLD) and type 2 diabetes prompts physicians to improve strategies for the diagnosis, prevention, and treatment of these metabolic conditions. Objective: to investigate the effects of glucagon-like peptide-1 rece...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu.M. Stepanov, O.V. Zinych, I.A. Klenina, K.O. Shyshkan-Shyshova, N.M. Kushnarоva
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2025-06-01
Series:Gastroenterologìa
Subjects:
Online Access:https://gastro.zaslavsky.com.ua/index.php/journal/article/view/675
Tags: Add Tag
No Tags, Be the first to tag this record!